- Home
- HTCR vs BCTX Comparison
HTCR vs BCTX Comparison
Compare HTCR & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- BCTX
- Stock Information
- Founded
- HTCR 2009
- BCTX 2014
- Country
- HTCR Japan
- BCTX Canada
- Employees
- HTCR N/A
- BCTX N/A
- Industry
- HTCR EDP Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- HTCR Technology
- BCTX Health Care
- Exchange
- HTCR Nasdaq
- BCTX Nasdaq
- Market Cap
- HTCR 11.9M
- BCTX 15.8M
- IPO Year
- HTCR 2022
- BCTX N/A
- Fundamental
- Price
- HTCR $0.63
- BCTX $0.73
- Analyst Decision
- HTCR
- BCTX Strong Buy
- Analyst Count
- HTCR 0
- BCTX 1
- Target Price
- HTCR N/A
- BCTX $18.00
- AVG Volume (30 Days)
- HTCR 36.8K
- BCTX 161.8K
- Earning Date
- HTCR 08-14-2024
- BCTX 10-23-2024
- Dividend Yield
- HTCR 12.60%
- BCTX N/A
- EPS Growth
- HTCR N/A
- BCTX N/A
- EPS
- HTCR N/A
- BCTX N/A
- Revenue
- HTCR $17,129,427.00
- BCTX N/A
- Revenue This Year
- HTCR $36.82
- BCTX N/A
- Revenue Next Year
- HTCR $21.49
- BCTX N/A
- P/E Ratio
- HTCR N/A
- BCTX N/A
- Revenue Growth
- HTCR N/A
- BCTX N/A
- 52 Week Low
- HTCR $0.36
- BCTX $0.52
- 52 Week High
- HTCR $1.25
- BCTX $7.18
- Technical
- Relative Strength Index (RSI)
- HTCR 45.93
- BCTX 48.20
- Support Level
- HTCR $0.55
- BCTX $0.68
- Resistance Level
- HTCR $0.68
- BCTX $0.88
- Average True Range (ATR)
- HTCR 0.06
- BCTX 0.08
- MACD
- HTCR -0.00
- BCTX 0.01
- Stochastic Oscillator
- HTCR 30.67
- BCTX 54.24
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.